MAPK11 and cancer: Therefore, the different levels of methylation within the CpG islands of MAPK11 between normal and cancer data sets may influence the decrease in expression of MAPK11 seen in cancer tissues and warrants further investigation as a possible biomarker (Figs. 2, 3, 4) [60].